Literature DB >> 8278311

Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing.

M E Mennie1, A Gilfillan, M E Compton, W A Liston, D J Brock.   

Abstract

Among 2207 women eligible to be screened for cystic fibrosis (CF) carrier status during pregnancy, 325 (15 per cent) declined to be tested. Of these, 260 (80 per cent) answered a questionnaire soliciting their reasons for not participating. The main factor was opposition to termination of pregnancy, with 43 per cent being against termination for any reason and another 11 per cent against termination of a CF fetus. Other reasons given were partner's disapproval or non-participation (10 per cent), perceived risk of a CF child being low (7 per cent), the error rate of the test (6 per cent), and the generation of unacceptable levels of anxiety (5 per cent). Eleven women (4 per cent) said that they did not wish to be tested during pregnancy, but only six of these would have accepted screening at another time.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction; Simpson Memorial Maternity Pavilion (Edinburgh)

Mesh:

Year:  1993        PMID: 8278311     DOI: 10.1002/pd.1970130904

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

Authors:  W W Grody; C Dunkel-Schetter; Z H Tatsugawa; M A Fox; C Y Fang; R M Cantor; J M Novak; H N Bass; B F Crandall
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

4.  Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Elinor Langfelder-Schwind; Edward Kloza; Elaine Sugarman; Barbara Pettersen; Trisha Brown; Kim Jensen; Seth Marcus; Joy Redman
Journal:  J Genet Couns       Date:  2005-02       Impact factor: 2.537

Review 5.  The Special Features of Prenatal and Preimplantation Genetic Counseling in Arab Countries.

Authors:  Shaza D Malik; Mashael Al-Shafai; Atiyeh M Abdallah
Journal:  Genes (Basel)       Date:  2022-01-18       Impact factor: 4.096

6.  Influence of five years of antenatal screening on the paediatric cystic fibrosis population in one region.

Authors:  S Cunningham; T Marshall
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

7.  Antenatal screening for cystic fibrosis: a trial of the couple model.

Authors:  J Livingstone; R A Axton; A Gilfillan; M Mennie; M Compton; W A Liston; A A Calder; A J Gordon; D J Brock
Journal:  BMJ       Date:  1994-06-04

8.  Female and male perspectives on male partner roles in expanded carrier screening.

Authors:  Sarah Jurgensmeyer; Sarah Walterman; Andrew Wagner; Kenny Wong; Annie Bao; Sarah Stueber; Sara Spencer
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.